|
Volumn 369, Issue 21, 2013, Pages 2066-2067
|
The authors and a colleague reply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOGLOBULIN G ANTIBODY;
IMMUNOGLOBULIN M ANTIBODY;
VALGANCICLOVIR;
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
GANCICLOVIR;
CANCER INHIBITION;
CANCER SURVIVAL;
CYTOMEGALOVIRUS;
DNA TRANSCRIPTION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GLIOBLASTOMA;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LETTER;
NONHUMAN;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RNA SEQUENCE;
RNA TRANSCRIPTION;
SURVIVAL RATE;
SURVIVAL TIME;
VIRUS REPLICATION;
WESTERN BLOTTING;
ANIMAL;
BRAIN TUMOR;
NOTE;
ANIMALS;
ANTIVIRAL AGENTS;
BRAIN NEOPLASMS;
GANCICLOVIR;
GLIOBLASTOMA;
HUMANS;
|
EID: 84889850876
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1312413 Document Type: Letter |
Times cited : (15)
|
References (5)
|